Yongin-si, South Korea

Si Beum Lee

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Si Beum Lee

Introduction

Si Beum Lee is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative methods in drug production. His work exemplifies the intersection of chemistry and medicine, showcasing the importance of innovation in healthcare.

Latest Patents

Si Beum Lee holds a patent for an improved production method for adefovir dipivoxil. This method is characterized by the use of dimethylsulfoxide as a reaction solvent. The process involves allowing adefovir to react with chloromethylpivalate at a controlled temperature of 30 to 50 degrees Celsius, utilizing dimethylsulfoxide and triethylamine as solvents. This innovative approach enhances the efficiency of producing adefovir dipivoxil, which is crucial in the treatment of viral infections.

Career Highlights

Si Beum Lee is associated with CJ Cheiljedang Corporation, a leading company in the food and biotechnology sectors. His role at the company allows him to apply his expertise in pharmaceutical innovations, contributing to advancements in drug development and production.

Collaborations

Si Beum Lee has collaborated with notable colleagues, including Kwang Do Choi and Yong Tack Lee. These collaborations highlight the importance of teamwork in driving innovation and achieving breakthroughs in research and development.

Conclusion

Si Beum Lee's contributions to the field of pharmaceuticals through his innovative patent demonstrate the vital role of inventors in advancing healthcare solutions. His work not only enhances drug production methods but also reflects the collaborative spirit of scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…